Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Idexx Laboratories
IDXX
$46.2B
| $60.9M | 0.02% |
149,261
-13,204
| -8% | -$5.13M |
|
652
Avista
AVA
$3.22B
| $60.7M | 0.02% |
1,367,884
-2,791
| -0.2% | -$112K |
|
653
Everest Group
EG
$14.3B
| $60.6M | 0.02% |
182,883
-86
| -0% | -$26.8K |
|
|
BSX.PRA
654
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $60.5M | 0.02% |
527,050
-50,000
| -9% | -$5.51M |
|
655
Invesco Senior Loan ETF
BKLN
$6.8B
| $60M | 0.02% |
2,923,208
+12,538
| +0.4% | +$260K |
|
656
Columbia Multi-Sector Municipal Income ETF
MUST
$594M
| $60M | 0.02% |
2,976,300
+287,315
| +11% | +$5.7M |
|
657
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
| $60M | 0.02% |
452,958
-3,156
| -0.7% | -$422K |
|
658
Insmed
INSM
$21.8B
| $59.9M | 0.02% |
3,000,301
+94,095
| +3% | +$1.82M |
|
659
Colliers International
CIGI
$5.13B
| $59.9M | 0.02% |
650,857
+1,286
| +0.2% | +$119K |
|
|
SPYM
660
State Street SPDR Portfolio S&P 500 ETF
SPYM
$167B
| $59.4M | 0.02% |
1,320,094
+176,080
| +15% | +$7.96M |
|
661
Keysight
KEYS
$58.2B
| $59.3M | 0.02% |
346,634
+6,381
| +2% | +$1.09M |
|
662
Copart
CPRT
$26.6B
| $59.1M | 0.02% |
1,942,504
-13,180
| -0.7% | -$395K |
|
663
Icon
ICLR
$12.7B
| $59M | 0.02% |
303,775
-8,873
| -3% | -$1.76M |
|
664
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.97B
| $58.7M | 0.02% |
1,266,724
+16,110
| +1% | +$751K |
|
665
WisdomTree US MidCap Dividend Fund
DON
$4.1B
| $58.7M | 0.02% |
1,427,205
+29,029
| +2% | +$1.2M |
|
666
Yeti Holdings
YETI
$3.98B
| $58.6M | 0.02% |
1,419,527
-1,079,437
| -43% | -$40.5M |
|
667
Bunge Global
BG
$20.6B
| $58.4M | 0.02% |
585,208
-9,624
| -2% | -$924K |
|
668
FTI Consulting
FCN
$4.29B
| $58.4M | 0.02% |
367,731
+120,074
| +48% | +$20M |
|
669
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.57B
| $58M | 0.02% |
584,030
-351,537
| -38% | -$35.1M |
|
670
Coca-Cola Europacific Partners
CCEP
$47.5B
| $57.9M | 0.02% |
1,055,333
+44,980
| +4% | +$2.26M |
|
671
UMB Financial
UMBF
$11.2B
| $57.7M | 0.02% |
690,539
+9,386
| +1% | +$789K |
|
672
iShares MSCI Taiwan ETF
EWT
$10.6B
| $57.6M | 0.02% |
1,458,999
+300,089
| +26% | +$13.4M |
|
673
Forward Air
FWRD
$473M
| $57.5M | 0.02% |
547,810
+374,828
| +217% | +$39.3M |
|
674
Merit Medical Systems
MMSI
$5.17B
| $57.4M | 0.02% |
813,077
-36,391
| -4% | -$2.43M |
|
675
Fortune Brands Innovations
FBIN
$6.22B
| $57.4M | 0.02% |
1,004,604
+130,047
| +15% | +$6.84M |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.